Uncategorized
Noveome Debuts with Top-Line Data from Three Phase 1 Clinical Trials
PITTSBURGH--(BUSINESS WIRE)--Noveome Biotherapeutics, leveraging the science of paracrine signaling, debuts with top-line data from 3 Phase 1 clinical trials and will enter Phase 2 testing this year.
